Accelerating Science: How to cure the incurable with cell and gene therapy

Amyloid MS Service by Shimadzu Corporation

For the rapid detection of Alzheimer’s Disease in blood. Shimadzu recently developed the Amyloid Mass Spectrometry (MS) Service — a new simple, low-cost blood test for early screening of amyloid-positive subjects. This method enables early and accurate detection of amyloid deposition in the brain with an easy-to-acquire blood sample. Unlike conventional methods, Shimadzu’s new test is minimally invasive, cost-effective and suitable for large-scale deployment.


Amyloid MS Service by Shimadzu Corporation product image
Amyloid MS Service


0 Scientists have reviewed this product


Write the First Review

No Reviews

For the rapid detection of Alzheimer’s Disease in blood. Shimadzu recently developed the Amyloid Mass Spectrometry (MS) Service — a new simple, low-cost blood test for early screening of amyloid-positive subjects. This method enables early and accurate detection of amyloid deposition in the brain with an easy-to-acquire blood sample. Unlike conventional methods, Shimadzu’s new test is minimally invasive, cost-effective and suitable for large-scale deployment. It is currently the only blood test capable of detecting abnormal amyloid-beta deposition in the brain with 90% accuracy.

 

Shimadzu’s Amyloid MS Service offers:

  • Reduced costs per test
  • A less invasive blood-based sampling technique
  • Low sample volume requirements (0.5 mL)

 
Shimadzu has built an efficient process for analyzing samples:

  • Samples are collected and shipped to Shimadzu.
  • Shimadzu analyzes the samples.
  • Shimadzu sends a detailed report via electronic format

Product Overview